Konchak Juleigh Nowinski, Moran Margaret R, O'Brien Matthew J, Kandula Namratha R, Ackermann Ronald T
Preventive Medicine Residency, Cook County Health and Hospitals System, 1900 W Polk Street, Room 901, Chicago, IL, 60612, USA.
Department of Medicine, Feinberg School of Medicine, 750 N. Lake Shore Drive, Suite 680, Chicago, IL, 60611, USA.
Curr Diab Rep. 2016 Jun;16(6):55. doi: 10.1007/s11892-016-0742-6.
Type 2 diabetes is a major public health problem in the USA, affecting over 12 % of American adults and imposing considerable health and economic burden on individuals and society. There is a strong evidence base demonstrating that lifestyle behavioral changes and some medications can prevent or delay the onset of type 2 diabetes in high risk adults, and several policy and healthcare system changes motivated by the Patient Protection and Affordable Care Act (ACA) have the potential to accelerate diabetes prevention. In this narrative review, we (1) offer a conceptual framework for organizing how the ACA may influence diabetes prevention efforts at the level of individuals, healthcare providers, and health systems; (2) highlight ACA provisions at each of these levels that could accelerate type 2 diabetes prevention nationwide; and (3) explore possible policy gaps and opportunity areas for future research and action.
2型糖尿病是美国的一个主要公共卫生问题，影响着超过12%的美国成年人，给个人和社会带来了相当大的健康和经济负担。有充分的证据表明，生活方式行为改变和一些药物可以预防或延缓高危成年人2型糖尿病的发病，《患者保护与平价医疗法案》（ACA）推动的多项政策和医疗保健系统变革有可能加速糖尿病预防。在这篇叙述性综述中，我们（1）提供一个概念框架，以组织ACA在个人、医疗保健提供者和卫生系统层面可能如何影响糖尿病预防工作；（2）强调在这些层面上的ACA条款，这些条款可以在全国范围内加速2型糖尿病的预防；（3）探讨未来研究和行动可能存在的政策差距和机会领域。
